Award notice Supplies
Suministro de medicamentos de uso humano de fabricación industrial biológicos/biosimilares bevacizumab, etanercept, infliximab, filgrastim y pegfilgrastim con destino al Servicio Canario de la Salud.
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- Dirección General de Recursos Económicos del Servicio Canario de la Salud
Las Palmas de Gran Canaria - Place of performance
- Las Palmas de Gran Canaria
- Estimated value
- €8,272,827 excl. VAT
- Amount awarded
- €16,545,654 excl. VAT
- Bids received
- 2
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 13 July 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Suministro de medicamentos de uso humano de fabricación industrial biológicos/biosimilares (bevacizumab, etanercept, infliximab, filgrastim y pegfilgrastim) con destino al Servicio Canario de la Salud, mediante acuerdo marco, por procedimiento abierto y tramitación ordinaria, sujeto a regulación armonizada.
Awarded to
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €202,502
- Median
- €425,325
- A quarter above
- €1,046,198
Amounts awarded (excl. VAT) over the last 3 years for 163 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 482266-2026.